Advertisement

Topics

Dementia Discovery Fund Company Profile

16:49 EDT 22nd September 2018 | BioPortfolio

For further information, please visit the DDF website at www.theddfund.com


News Articles [1266 Associated News Articles listed on BioPortfolio]

The Dementia Discovery Fund Raises $350 Million from Investors AARP, NFL and Others

The Dementia Discovery Fund (DDF), a venture capital fund focused solely on dementia-related investments, completed $350 million of fundraising. The initial target was $200 million.

Finance Watch: Dementia Discovery Fund Exceeds Fundraising Goal By $150m

Private Company Edition: The Dementia Discovery Fund started in 2015 with plans to raise $200m to fund early-stage development of...   

International Fund Raises €300M for Dementia Research

The Dementia Discovery Fund has raised $350M (€300M) to support industrial and academic scientists doing early-stage research to develop new dementia medicines. Launched in 2015, the Dementia Discov...

The Dementia Discovery Fund raises $350m

The Dementia Discovery Fund (DDF) has announced the completion of its fundraising, with £250m ($350m at the time of completion) raised from an influential group of strategic investors committed to de...

Dementia Discovery Fund gets assistance with final close from the Aztec Group

The Aztec Group, an independent fund and corporate services provider, has assisted the Dementia Discovery Fund (DDF) with its final close and will continue to support the fund during its administratio...

AARP invests in Dementia Discovery Fund to kick─start Disrupt Dementia Campaign

With nearly 10 million new cases of dementia and Alzheimer's disease occurring each year, and no cure, today AARP launched a new campaign, "Disrupt Dementia." The campaign aims to help drive new diagn...

Eisai accelerates dementia drug discovery research

Eisai is launching a special dementia discovery centre to boost development of next-generation medicines targeting forms of the condition, including Alzheimer’s disease. The new Center for Genetic...

Eisai Plans Invests $100M in Genetics Guided Dementia Discovery Facility in Cambridge, Mass.

Eisai Inc. is adding to its arsenal aimed at combating dementia. The company will launch the Eisai Center for Genetics Guided Dementia Discovery.

Drugs and Medications [78 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Exelon [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use Exelon  Patch safely and effectively. See full prescribing information for Exelon Patch.       Exelon  Patch (rivastig

Risperidone [WOCKHARDT USA LLC]

These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone. Risperidone Tablets Initial U.S. Approval : 1993

Risperidone [WOCKHARDT LIMITED]

These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone. Risperidone Tablets Initial U.S. Approval : 1993

Fluphenazine hydrochloride [Sandoz Inc]

Fluphenazine Hydrochloride Tablets, USP

PubMed Articles [1157 Associated PubMed Articles listed on BioPortfolio]

Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale.

The first National Research Summit on Care, Services, and Supports for Persons with Dementia and Their Caregivers was held on October 16-17, 2017, at the National Institutes of Health. In this paper, ...

A Dementia Café as a Bridgehead for Community-Inclusive Care: Qualitative Analysis of Observations by On-the-Job Training Participants in a Dementia Café.

Dementia cafés are becoming widespread as a new approach to dementia care, but their operational procedures and significance have not been adequately studied.

The Ultimate Disaster? Dementia between Personal Experience and Social Representation.

Dementia is widely regarded as one of the greatest threats to a good and dignified life in old age, a condition so terrifying that even death appears preferable. This contribution is dedicated to a cr...

Clinical periodontal variables in patients with and without dementia-a systematic review and meta-analysis.

Considering the increasing number of elderly people, dementia has gained an important role in today's society. Although the contributing factors for dementia have not been fully understood, chronic pe...

Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index.

Selecting high-risk participants for dementia prevention trials based on a modifiable dementia risk score may be advantageous, as it increases the opportunity for intervention. We studied whether a mu...

Clinical Trials [933 Associated Clinical Trials listed on BioPortfolio]

Resource Use and Disease Course in Dementia (REDIC)

This project is based on a three-year program that aims to improve the knowledge of the socioeconomic consequences of dementia in Norway. By including patients with and without dementia in...

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Dementia in Parkinson Disease

The purpose of this study is to use a brain imaging method called PIB PET VAT PET to determine dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is ...

A Randomized Controlled Trial on the Effect of Exercise on Physical, Cognitive and Affective Function in Dementia Subjects

Studies have shown conflicting results of the effect of exercise on dementia patients. The aim of this study is to examine the role of physical activity on the risk of cognitive impairmen...

The Women's Health Initiative Memory Study (The WHIMS Study)

Excessive memory decline or dementia affects an increasing number of women as they become older. The frequency of dementia doubles every 5 years beginning at age 60, making the discovery o...

Companies [1639 Associated Companies listed on BioPortfolio]

Dementia Discovery Fund

For further information, please visit the DDF website at www.theddfund.com

Alector, Inc.

Alector is a privately owned biotechnology company whose mission is to develop therapies that harness the immune system to treat neurodegenerative diseases and cancer. Alector was...

BioPharma Fund

BioPharma Fund is an investment fund that invests in shares of medical biotechnology companies. Biotechnology companies are developing new drugs for many diseases such as cancer, heart disease, diabet...

OS Fund

OS Fund invests in entrepreneurs using applied intelligence to commercialize breakthrough discoveries in genomics, synthetic biology, diagnostics, new materials, and data and ener...

Alzheimer's Drug Discovery Foundation

The ADDF is the only public charity whose sole mission is to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. Si...

More Information about "Dementia Discovery Fund" on BioPortfolio

We have published hundreds of Dementia Discovery Fund news stories on BioPortfolio along with dozens of Dementia Discovery Fund Clinical Trials and PubMed Articles about Dementia Discovery Fund for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dementia Discovery Fund Companies in our database. You can also find out about relevant Dementia Discovery Fund Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record